Are You at Risk for Essential Thrombocythemia?

Published: Sep 11, 2023

Understanding the risk factors for Essential Thrombocythemia (ET) can help in early detection and management. Discover who is more likely to develop this condition and how.
Contents

Genetic Factors

ET is often linked to genetic mutations, particularly in the JAK2, CALR, and MPL genes. These mutations can be somatically acquired, meaning they occur after birth, and they play a significant role in the development of the condition. Identifying these mutations is crucial for diagnosis and understanding an individual's risk.

Demographic Influences

The likelihood of developing ET varies based on age, sex, and race. It is more common in individuals over 60 and affects women more frequently than men. Certain ethnic groups also show different incidence rates, with Black Americans having a higher occurrence than White Americans.
Explores the genetic and demographic risk factors associated with Essential Thrombocythemia, including JAK2, CALR, and MPL gene mutations, as well as age, sex, and racial influences.

Lifestyle and Health Factors

While genetic factors are significant, lifestyle and other health conditions can influence ET risk. Factors such as cardiovascular health, smoking, and diabetes can impact the severity and complications of ET. Regular health check-ups can help manage these risks.

Frequently Asked Questions

Mutations in JAK2, CALR, and MPL genes are linked to ET.

People over 60 years old are most affected.

Yes, lifestyle factors like smoking and diabetes can affect ET risk.

Key Takeaways

Knowing your risk factors is the first step towards managing ET effectively.
Discover your ET risk factors with Doctronic's guidance today!

Related Articles

References

  1. Srour SA, Devesa SS, Morton LM, et al. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12. Br J Haematol 2016; 174:382.
  2. Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 2017; 129:680.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely